Implications of Contact Days in the Treatment of Relapsed Refractory Diffuse Large B-Cell Lymphoma

This commentary remarks on a recently published study assessing clinic contact days for patients enrolled in the Canadian Cancer Trials Group LY.12 clinical trial.

Detalles Bibliográficos
Autores principales: Bojanini, Leyla, Gupta, Neel, Khaki, Ali Raza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485298/
https://www.ncbi.nlm.nih.gov/pubmed/37432278
http://dx.doi.org/10.1093/oncolo/oyad204
_version_ 1785102754276966400
author Bojanini, Leyla
Gupta, Neel
Khaki, Ali Raza
author_facet Bojanini, Leyla
Gupta, Neel
Khaki, Ali Raza
author_sort Bojanini, Leyla
collection PubMed
description This commentary remarks on a recently published study assessing clinic contact days for patients enrolled in the Canadian Cancer Trials Group LY.12 clinical trial.
format Online
Article
Text
id pubmed-10485298
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-104852982023-09-09 Implications of Contact Days in the Treatment of Relapsed Refractory Diffuse Large B-Cell Lymphoma Bojanini, Leyla Gupta, Neel Khaki, Ali Raza Oncologist Commentary This commentary remarks on a recently published study assessing clinic contact days for patients enrolled in the Canadian Cancer Trials Group LY.12 clinical trial. Oxford University Press 2023-07-11 /pmc/articles/PMC10485298/ /pubmed/37432278 http://dx.doi.org/10.1093/oncolo/oyad204 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Bojanini, Leyla
Gupta, Neel
Khaki, Ali Raza
Implications of Contact Days in the Treatment of Relapsed Refractory Diffuse Large B-Cell Lymphoma
title Implications of Contact Days in the Treatment of Relapsed Refractory Diffuse Large B-Cell Lymphoma
title_full Implications of Contact Days in the Treatment of Relapsed Refractory Diffuse Large B-Cell Lymphoma
title_fullStr Implications of Contact Days in the Treatment of Relapsed Refractory Diffuse Large B-Cell Lymphoma
title_full_unstemmed Implications of Contact Days in the Treatment of Relapsed Refractory Diffuse Large B-Cell Lymphoma
title_short Implications of Contact Days in the Treatment of Relapsed Refractory Diffuse Large B-Cell Lymphoma
title_sort implications of contact days in the treatment of relapsed refractory diffuse large b-cell lymphoma
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485298/
https://www.ncbi.nlm.nih.gov/pubmed/37432278
http://dx.doi.org/10.1093/oncolo/oyad204
work_keys_str_mv AT bojaninileyla implicationsofcontactdaysinthetreatmentofrelapsedrefractorydiffuselargebcelllymphoma
AT guptaneel implicationsofcontactdaysinthetreatmentofrelapsedrefractorydiffuselargebcelllymphoma
AT khakialiraza implicationsofcontactdaysinthetreatmentofrelapsedrefractorydiffuselargebcelllymphoma

Ejemplares similares